相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease
Geert D'Haens et al.
INFLAMMATORY BOWEL DISEASES (2012)
Levels of C-reactive Protein Are Associated With Response to Infliximab Therapy in Patients With Crohn's Disease
Matthias Jurgens et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
The Utility of Biomarkers in the Diagnosis and Therapy of Inflammatory Bowel Disease
James D. Lewis
GASTROENTEROLOGY (2011)
Evaluation of disease activity in IBD at the time of diagnosis by the use of clinical, biochemical, and fecal markers
Petr Ricanek et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2011)
Endoscopic Evaluation of Crohn's Disease Activity: Comparison of the CDEIS and the SES-CD
Taina Sipponen et al.
INFLAMMATORY BOWEL DISEASES (2010)
Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn's disease treatment
Taina Sipponen et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2010)
Faecal calprotectin in children with clinically quiescent inflammatory bowel disease
Taina Sipponen et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2010)
Ulcerative Colitis: Correlation of the Rachmilewitz Endoscopic Activity Index with Fecal Calprotectin, Clinical Activity, C-reactive Protein, and Blood Leukocytes
Alain M. Schoepfer et al.
INFLAMMATORY BOWEL DISEASES (2009)
Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn's disease and histological findings
T. Sipponen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Comparison of Interferon-Gamma Release Assay Versus Tuberculin Skin Test for Tuberculosis Screening in Inflammatory Bowel Disease
Alain M. Schoepfer et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Mesalamine Foam Enema Versus Mesalamine Liquid Enema in Active Left-Sided Ulcerative Colitis
Antoine Cortot et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Potential to inhibit growth of atherosclerotic plaque development through modulation of macrophage neopterin/7,8-dihydroneopterin synthesis
S. P. Gieseg et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Relationships Between Disease Activity and Serum and Fecal Biomarkers in Patients With Crohn's Disease
Jennifer Jones et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Urinary Neopterin Is a Valuable Tool in Monitoring Crohn's Disease Activity
S. Nancey et al.
INFLAMMATORY BOWEL DISEASES (2008)
Fecal Calprotectin, Lactoferrin, and Endoscopic Disease Activity in Monitoring Anti-TNF-alpha Therapy for Crohn's Disease
Taina Sipponen et al.
INFLAMMATORY BOWEL DISEASES (2008)
Accuracy of four fecal assays in the diagnosis of colitis
Alain M. Schoepfer et al.
DISEASES OF THE COLON & RECTUM (2007)
Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease
Renata D'Inca et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2007)
Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD
M Daperno et al.
GASTROINTESTINAL ENDOSCOPY (2004)
Relationship between fecal calprotectin, intestinal inflammation, and peripheral blood neutrophils in patients with active ulcerative colitis
H Hanai et al.
DIGESTIVE DISEASES AND SCIENCES (2004)